Abstract
Despite the improvement of diagnostic and therapeutic techniques age-related macular degeneration is still one of the main causes of central vision impairment.
 Throughout the years, the classification of subretinal neovascularization in the course of age-related macular degeneration has changed due to the advancement of diagnostic and therapeutic techniques. In 2020 an expert panel reached consensus on a new nomenclature for neovascularization in the course of age-related macular degeneration introducing the concept of macular neovascularization, which refers to each neovascularization in macula, regardless of the location.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have